Akero Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:AKRO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Mar 24	SellUS$18,443	Jonathan Young	Individual	651	US$28.33
13 Mar 24	SellUS$20,483	Catriona Yale	Individual	723	US$28.33
13 Mar 24	SellUS$20,511	William White	Individual	724	US$28.33
13 Mar 24	SellUS$55,782	Andrew Cheng	Individual	1,969	US$28.33
13 Mar 24	SellUS$17,536	Timothy Rolph	Individual	619	US$28.33
14 Dec 23	SellUS$11,273	Jonathan Young	Individual	543	US$20.76
14 Dec 23	SellUS$10,671	Timothy Rolph	Individual	514	US$20.76
14 Dec 23	SellUS$12,394	Catriona Yale	Individual	597	US$20.76
14 Dec 23	SellUS$33,797	Andrew Cheng	Individual	1,628	US$20.76
14 Dec 23	SellUS$12,684	William White	Individual	611	US$20.76
08 Dec 23	BuyUS$1,982,940	Logos Global Management, L.P.	Company	100,000	US$19.85
01 Dec 23	BuyUS$1,694,565	Logos Global Management, L.P.	Company	100,000	US$16.99
17 Nov 23	SellUS$440,259	Jonathan Young	Individual	30,000	US$14.68
08 Aug 23	BuyUS$1,051,475	Logos Global Management, L.P.	Company	25,000	US$42.06
01 Aug 23	BuyUS$2,362,234	Logos Global Management, L.P.	Company	55,000	US$43.26
23 Jun 23	SellUS$1,725,390	Catriona Yale	Individual	33,349	US$52.26
20 Jun 23	SellUS$180,235	William White	Individual	3,277	US$55.00
16 Jun 23	SellUS$2,101,066	Timothy Rolph	Individual	38,200	US$56.30

Insider Buying: AKRO insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25%.

Top 25 shareholders own 92.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.85%	Janus Henderson Group plc	6,121,970	US$121.9m	42.2%	0.05%
7.86%	RTW Investments, LP	5,431,985	US$108.2m	51.2%	1.85%
7.57%	General Atlantic Service Company, L.P.	5,233,989	US$104.3m	193%	1.79%
7.54%	Wellington Management Group LLP	5,213,364	US$103.9m	80.9%	0.02%
7.47%	T. Rowe Price Group, Inc.	5,162,528	US$102.8m	40.4%	0.01%
7.08%	BlackRock, Inc.	4,892,616	US$97.5m	17%	no data
5.49%	State Street Global Advisors, Inc.	3,797,730	US$75.7m	-25.9%	no data
5.31%	The Vanguard Group, Inc.	3,669,923	US$73.1m	19%	no data
4.04%	Alkeon Capital Management, LLC	2,793,653	US$55.6m	-11.9%	0.4%
3.92%	Baker Bros. Advisors LP	2,713,205	US$54.0m	14.6%	0.65%
3.65%	Pfizer Inc.	2,525,252	US$50.3m	0%	no data
2.69%	Redmile Group, LLC	1,858,702	US$37.0m	67.5%	1.5%
2.42%	Tavistock Life Sciences	1,676,733	US$33.4m	0%	1.82%
2.34%	AllianceBernstein L.P.	1,621,262	US$32.3m	0.84%	0.01%
2.07%	Yiheng Capital Management, L.P.	1,434,179	US$28.6m	-25.5%	3.48%
2.05%	Geode Capital Management, LLC	1,419,307	US$28.3m	21.7%	no data
2.01%	Perceptive Advisors LLC	1,387,471	US$27.6m	43.4%	0.56%
1.93%	Fred Alger Management, LLC	1,336,881	US$26.6m	1,370%	0.14%
1.88%	Rock Springs Capital Management LP	1,299,888	US$25.9m	20.2%	0.73%
1.39%	Emerald Advisers, LLC	963,774	US$19.2m	277%	0.45%
1.16%	Logos Global Management, L.P.	800,000	US$15.9m	0%	1.96%
1.15%	Millennium Management LLC	792,575	US$15.8m	208%	0.01%
1.01%	Schonfeld Strategic Advisors LLC	695,723	US$13.9m	418%	0.12%
0.94%	Point72 Asset Management, L.P.	651,424	US$13.0m	0.29%	0.03%
0.86%	Northern Trust Global Investments	597,688	US$11.9m	10.5%	no data